The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEkf Diagnostics Regulatory News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.50
Bid: 31.60
Ask: 32.30
Change: 0.30 (0.93%)
Spread: 0.70 (2.215%)
Open: 32.10
High: 32.50
Low: 32.00
Prev. Close: 32.20
EKF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investor Presentation – Revised start time

15 Mar 2024 07:00

RNS Number : 9464G
EKF Diagnostics Holdings PLC
15 March 2024
 

 

EKF Diagnostics Holdings plc

("EKF", the "Company", or the "Group")

 

 Investor Presentation - Revised start time

 

EKF Diagnostics Holdings plc (AIM: EKF), the?AIM-listed global diagnostics business, announces a revised start time for its investor presentation taking place on Wednesday 20 March 2024.

 

Julian Baines, Executive Chair, and Stephen Young, Chief Financial Officer, will be hosting a live online presentation relating to the Company's full year results via the Investor Meet Company platform at the revised time of 3pm GMT on Wednesday 20 March 2024. The presentation is open to all existing and potential shareholders.

 

Investors can sign up to Investor Meet Company for free and register for the presentation here: https://www.investormeetcompany.com/ekf-diagnostics-holdings-plc/register-investor

 

Investors who already follow EKF on the Investor Meet Company platform will automatically be invited to the event at the new start time.

 

If the new time is no longer convenient, please note that a recording of the presentation, a PDF of the slides used, and responses to the Q&A session will be available on the Investor Meet Company platform afterwards.

 

 

EKF Diagnostics Holdings plc

www.ekfdiagnostics.com

Julian Baines, Executive Chair / Stephen Young, CFO

 Tel: +44 (0)29 2071 0570

Singer Capital Markets (Nominated Adviser & Joint Broker)

Tel: +44 (0)20 7496 3000

Aubrey Powell / Oliver Platts

Walbrook PR Limited

Tel: +44 (0)20 7933 8780 or ekf@walbrookpr.com

Paul McManus / Charlotte Edgar

Mob: +44 (0)7980 541 893 / +44 (0)7884 664 686

 

 

About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)

 

EKF is an AIM-listed global diagnostics business focussed on:

 

· Point-of-Care analysers in the key areas of Hematology and Diabetes, as well as Central Laboratory products including clinical chemistry reagents, analysers and centrifuges

 

· Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications, as well as other higher value Contract Manufacturing services

 

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASFEFWLELSEED
Date   Source Headline
20th Jun 201111:35 amRNSHolding(s) in Company
17th Jun 20114:00 pmRNSHolding(s) in Company
16th Jun 20113:59 pmRNSHolding(s) in Company
15th Jun 20119:51 amRNSResults of General Meeting
13th Jun 20117:00 amRNSAnnual Financial Report
23rd May 20117:00 amRNSFinal Results
23rd May 20117:00 amRNSProposed Acquisition and Placing
23rd May 20117:00 amRNSExclusive distribution agreement with Alere
9th May 20114:40 pmRNSSecond Price Monitoring Extn
9th May 20114:35 pmRNSPrice Monitoring Extension
10th Mar 20118:17 amRNSIssue of Equity following Exercise of Options
27th Jan 20117:00 amRNSSFDA approval for Quo-Test in China
26th Jan 20118:49 amPRNCompletion of Sale of Admiral trademarks in Europe
21st Jan 20119:35 amPRNCompletion of Sale of Admiral trademarks in the Americas
14th Jan 20119:44 amRNSCompletion of Sale of trademarks in UK & Ireland
24th Dec 20107:00 amRNSDisposal of Admiral Sportswear Brand
9th Dec 201010:06 amRNSHolding(s) in Company
2nd Dec 20107:00 amRNSAcquisition
5th Nov 201012:22 pmRNSDeed of Variation
6th Oct 20103:03 pmRNSHolding(s) in Company
4th Oct 20108:41 amRNSCompletion of Acquisition
1st Oct 20107:00 amRNSAcquisition - SPA signed
28th Sep 201011:06 amRNSHolding(s) in Company
24th Sep 201012:00 pmRNSSenior Executive Incentive Package
24th Sep 20107:00 amRNSContract win & new distributor
23rd Sep 20107:00 amRNSAcquisition
14th Sep 20107:00 amRNSHalf Yearly Report
30th Jul 20107:00 amRNSTotal Voting Rights
27th Jul 20107:00 amRNSDirectorate Change
21st Jul 20107:00 amRNSSale of the Admiral sports rights
19th Jul 20103:01 pmRNSHolding(s) in Company
9th Jul 20109:32 amRNSHolding(s) in Company
9th Jul 20108:24 amRNSHolding(s) in Company
2nd Jul 201012:16 pmRNSResult of General Meeting
2nd Jul 201012:15 pmRNSResult of AGM
18th Jun 20103:03 pmRNSSchedule 1 - International Brand Licensing plc
15th Jun 20107:00 amRNSAcquisition and Placing
10th Jun 20107:00 amRNSFinal Results
28th May 20107:00 amRNSSale of Admiral trademarks
29th Apr 20107:00 amRNSAppointment of Adviser
5th Jan 201011:30 amRNSDisposal
4th Jan 20101:44 pmRNSResult of General Meeting
11th Dec 20097:00 amRNSIssue of Circular and Option Arrangements
26th Nov 20097:00 amRNSBoard Changes, New Strategy, Disposal and Placing
14th Sep 20097:00 amRNSInterim Results
17th Aug 200911:41 amRNSSale of Admiral Trademarks
30th Jun 200911:23 amRNSResult of AGM
20th May 20097:00 amRNSFinal Results
27th Apr 20097:00 amRNSNew Partnership
13th Jan 20097:00 amRNSRe Joint Venture

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.